Related Experiment Video

Updated: May 10, 2026

Colony Formation Assay Detecting the Proliferative Capacity of LncRNA-knockdown Osteosarcoma Cells
06:13

Colony Formation Assay Detecting the Proliferative Capacity of LncRNA-knockdown Osteosarcoma Cells

Published on: January 16, 2026

Down-regulation of long non-coding RNA TUG1 inhibits osteosarcoma cell proliferation and promotes apoptosis

Qiang Zhang1, Pei-Liang Geng, Pei Yin

  • 1Department of Orthopedics, Chinese PLA General Hospital, Beijing, China.

Asian Pacific Journal of Cancer Prevention : APJCP
|June 4, 2013
PubMed
Abstract

Insights

TUG1 and its variant n377360 are overexpressed in osteosarcoma, inhibiting proliferation and promoting apoptosis. Targeting these factors may offer a novel therapeutic strategy for osteosarcoma treatment.

Area of Science:

  • Molecular biology
  • Oncology
  • Biochemistry

Background:

  • Osteosarcoma is a primary bone malignancy with limited therapeutic options.
  • Long non-coding RNAs (lncRNAs) play critical roles in cancer development.
  • TUG1 (Taurine-Upregulated Gene 1) is implicated in various cancers, but its role in osteosarcoma requires further investigation.

Purpose of the Study:

  • To determine the expression levels of TUG1 and its transcript variant n377360 in osteosarcoma.
  • To elucidate the functional role of TUG1 in osteosarcoma cell proliferation and apoptosis using the U2OS cell line.

Main Methods:

  • Real-time quantitative PCR (RT-qPCR) was used to measure TUG1 and n377360 expression in osteosarcoma tissues and cell lines.
  • Small interfering RNA (siRNA) was employed to suppress TUG1 and n377360 expression in U2OS cells.
  • MTS assay and flow cytometry were utilized to assess cell proliferation and apoptosis, respectively.

Main Results:

  • TUG1 and n377360 expression levels were significantly elevated in osteosarcoma tissues compared to non-tumorous tissues.
  • Suppression of TUG1 and n377360 via siRNA significantly reduced osteosarcoma cell proliferation.
  • Inhibition of TUG1 expression markedly increased osteosarcoma cell apoptosis.

Conclusions:

  • Overexpression of TUG1 and n377360 is a characteristic feature of osteosarcoma.
  • TUG1 plays a crucial role in regulating osteosarcoma cell proliferation and apoptosis.
  • Targeting TUG1 or n377360 represents a potential, yet unexplored, therapeutic avenue for osteosarcoma.

More Related Videos

RNA Fluorescence In Situ Hybridization for Long Non-Coding RNA Localization in Human Osteosarcoma Cells05:27

RNA Fluorescence In Situ Hybridization for Long Non-Coding RNA Localization in Human Osteosarcoma Cells

Published on: June 16, 2023

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...